Abstract: | Objective: To observe the clinical effect of the Shugan Jianpi pill. Methods: 50 cases of chronic hepatitis B in our hospital were chosen as the object of study, were randomly divided into the treated group and control group, 25 cases in each group, the treated group was treated with the Shugan Jianpi pills, while the control group was given to Lamivudine (LAM) treatment, continuous 6 months of treatment for 1 course, followed-up for 3 months after treatment, compared the clinical efficacy of two groups. Results: The total efficiency, ALT, AST, flank pain, anorexia and fatigue in the treated group were improved significantly than those in the control group (P〈0.01), with statistical significance. Conclusion: The efficacy of Shugan Jianpi pill are satisfactory in treating the liver stagnation and spleen asthenia syndrome of chronic hepatitis B, it was worthy of popularization and application. |